Live News EQUITY FLASH L impact Oct 26, 2026, 02:17 PM UTC Redeye Says Larger Cohort Confirms BioInvent BI-1808 Efficacy Redeye’s analyst says a larger cohort confirms efficacy for BioInvent’s BI-1808. SquawkNews Desk